Why the study?
Does cardiovascular autonomic neuropathy increase the risk of cardiovascular disease events in patients with type 1 diabetes?
Population
1,393 participants with type 1 diabetes from the DCCT/EDIC cohort
Comparison
Presence of cardiovascular autonomic neuropathy… vs Absence of cardiovascular autonomic neuropathy…
Design
Cohort
Authors
Loading...
May flag higher CVD risk in T1D with CAN; extends DCCT observations but leaves practice change open.
Does cardiovascular autonomic neuropathy increase the risk of cardiovascular disease events in patients with type 1 diabetes?
Cardiovascular autonomic neuropathy is associated with a higher long-term risk of CVD events in type 1 diabetes, though this risk is largely driven by historic glycemic exposure.
Pop‐Busui et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: